A research team led by Prof. Wang Hongzhi from the Hefei Institute of Physical Science of the Chinese Academy of Sciences has ...

Cancer kills many people and pets each year. Studies suggest that between one-third and one-half of dogs will develop cancer ...

In a blinded laboratory trial, trained biodetection dogs distinguished serum from dogs with hemangiosarcoma from control ...

Our job was to lead the research and prepare a prototype, and the final product will be delivered by the DRDO, a faculty member said, adding that proper field trials are yet to be conducted to ...

There's new hope for a devastating cancer in dogs that's often deadly because there are no early warning signs.

In a blinded laboratory trial, trained biodetection dogs distinguished serum from dogs with hemangiosarcoma from control samples with about 70% accuracy, supporting the idea that the tumor produces a ...

Cancer is a leading cause of death in both humans and pets; studies suggest that between one-third and one-half of all dogs ...

DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- The global pharmaceutical supply chain is currently ...

Niacinamide Peptides is the latest launch from the science-backed skincare brand, and new customers can currently bag 15% off ...

Cancer is a leading cause of death in both humans and pets; studies suggest that between one-third and one-half of all dogs will develop cancer during their lifetime. Hemangiosarcoma, an aggressive, ...

Cancer immunotherapy has transformed modern oncology by harnessing the body's own immune system to combat malignant disease. Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have produced ...